MYOZYME
Drug
GENZYME CORPORATION
Total Payments
$84,751
Transactions
151
Doctors
26
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $84,751 | 151 | 26 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $55,562 | 73 | 65.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,899 | 2 | 23.5% |
| Travel and Lodging | $5,816 | 30 | 6.9% |
| Food and Beverage | $1,932 | 41 | 2.3% |
| Unspecified | $1,543 | 5 | 1.8% |
Payments by Type
General
$83,209
146 transactions
Research
$1,543
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective Safety Sub-Registry to assess Anaphylaxis and severe allergic reactions, and severe cutaneous and systemic immune-mediated reactions with Alglucosidase Alfa Trea | GENZYME CORPORATION | $600.00 | 0 |
| Sanchez-Valle_61198078_Rare Disease Registry | GENZYME CORPORATION | $378.75 | 0 |
| Genzyme Rare Disease Registry | GENZYME CORPORATION | $300.00 | 0 |
| Sanchez-Valle_61198078-Rare Disease Registry | GENZYME CORPORATION | $138.75 | 0 |
| Genzyme Rare Disease Registry/IRB Fee Continuing Review/Progress Report/ PI Adams | GENZYME CORPORATION | $125.00 | 0 |
Top Doctors Receiving Payments for MYOZYME
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Priya Kishnani | Pediatrics | Durham, NC | $16,141 | 21 |
| , M.D.,PH.D | Neurology | Salt Lake City, UT | $13,625 | 7 |
| , MD | Clinical Genetics (M.D.) | Chicago, IL | $8,337 | 3 |
| , M.D | Internal Medicine | Detroit, MI | $6,490 | 16 |
| , MD | Pediatric Cardiology | Gainesville, FL | $4,417 | 8 |
| , M.D | Pulmonary Disease | New York, NY | $4,240 | 13 |
| , MD | Pediatrics | Springfield, MA | $3,398 | 12 |
| , MD | Clinical Genetics (M.D.) | Orange, CA | $3,356 | 11 |
| , M.D | Neurology | Phoenix, AZ | $2,682 | 4 |
| , MD | Specialist | Pittsburgh, PA | $2,455 | 10 |
| , M.D | Clinical Genetics (M.D.) | Cincinnati, OH | $1,987 | 5 |
| , MD, PHD | Clinical Genetics (M.D.) | Durham, NC | $1,850 | 5 |
| , M.D | Clinical Genetics (M.D.) | Cincinnati, OH | $1,579 | 1 |
| Unknown | — | New York, NY | $1,543 | 5 |
| , MD | Anatomic Pathology & Clinical Pathology | Columbia, MO | $1,372 | 3 |
| , MD | Pediatrics | Valhalla, NY | $1,372 | 3 |
| , MD, PHD | Clinical Biochemical Genetics | Seattle, WA | $1,372 | 3 |
| , MD | Pediatrics | Orange, CA | $1,372 | 3 |
| , MD | Neurology | Stanford, CA | $1,372 | 3 |
| , MD, PHD | Clinical Genetics (M.D.) | Decatur, GA | $1,372 | 3 |
| , M.D | Clinical Genetics (M.D.) | — | $1,372 | 3 |
| , MD | Clinical Biochemical Genetics | Austin, TX | $1,372 | 3 |
| , M.D., PHD | Clinical Genetics (M.D.) | Decatur, GA | $940.00 | 1 |
| , M.D | Neurology | Kansas City, KS | $478.00 | 2 |
| , MD | Neurology | Dallas, TX | $86.00 | 1 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $84,751
Product Information
- Type Drug
- Total Payments $84,751
- Total Doctors 26
- Transactions 151
About MYOZYME
MYOZYME is a drug associated with $84,751 in payments to 26 healthcare providers, recorded across 151 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2017. In 2017, $84,751 was paid across 151 transactions to 26 doctors.
The most common payment nature for MYOZYME is "Consulting Fee" ($55,562, 65.6% of total).
MYOZYME is associated with 5 research studies, including "A Prospective Safety Sub-Registry to assess Anaphylaxis and severe allergic reactions, and severe cutaneous and systemic immune-mediated reactions with Alglucosidase Alfa Trea" ($600.00).